Up-to-date approach in diagnosis and treatment of primary mediastinal B-cell lymphoma

被引:0
作者
Markovic, Olivera [1 ,2 ]
Cvetkovic, Zorica [2 ,3 ]
Bukurecki, Ilija [1 ]
Divac, Anica [1 ]
Stanisavljevic, Natasa [1 ,2 ]
Balint, Milena Todorovic [4 ]
Balint, Bela [5 ,6 ]
机构
[1] Clin Hosp Ctr Bezanijska Kosa, Clin Internal Med, Dept Hematol, Dr Zorza Matea Bb 11, 11080 Belgrade, Serbia
[2] Univ Belgrade, Fac Med, Belgrade, Serbia
[3] Univ Hosp Med Ctr Zemun, Dept Hematol, Clin Internal Med, Belgrade, Serbia
[4] Univ Clin Ctr Serbia, Clin Hematol, Belgrade, Serbia
[5] Serbian Acad Arts & Sci, Dept Med Sci, Belgrade, Serbia
[6] Univ Def, Fac Med, Mil Med Acad, Belgrade, Serbia
关键词
antineoplastic combined chemotherapy protocols; biomarkers; diagnosis; gene expression; histological techniques; lymphoma; large b-cell; diffuse; prognosis; tomography; emission-computed; RADIATION-THERAPY; R-EPOCH; RITUXIMAB; CHOP; IMMUNOCHEMOTHERAPY; MANAGEMENT; CHILDREN; OUTCOMES;
D O I
10.2298/VSP241015013M
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:133 / 139
页数:7
相关论文
共 54 条
[1]   Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001 [J].
Abramson, Jeremy S. ;
Palomba, M. Lia ;
Gordon, Leo I. ;
Lunning, Matthew ;
Wang, Michael ;
Arnason, Jon ;
Purev, Enkhtsetseg ;
Maloney, David G. ;
Andreadis, Charalambos ;
Sehgal, Alison ;
Solomon, Scott R. ;
Ghosh, Nilanjan ;
Dehner, Christine ;
Kim, Yeonhee ;
Ogasawara, Ken ;
Kostic, Ana ;
Siddiqi, Tanya .
BLOOD, 2024, 143 (05) :404-416
[2]   The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022) [J].
Alaggio, Rita ;
Amador, Catalina ;
Anagnostopoulos, Ioannis ;
Attygalle, Ayoma D. ;
de Oliveira Araujo, Iguaracyra Barreto ;
Berti, Emilio ;
Bhagat, Govind ;
Borges, Anita Maria ;
Boyer, Daniel ;
Calaminici, Mariarita ;
Chadburn, Amy ;
Chan, John K. C. ;
Cheuk, Wah ;
Chng, Wee-Joo ;
Choi, John K. ;
Chuang, Shih-Sung ;
Coupland, Sarah E. ;
Czader, Magdalena ;
Dave, Sandeep S. ;
de Jong, Daphne ;
Di Napoli, Arianna ;
Du, Ming-Qing ;
Elenitoba-Johnson, Kojo S. ;
Ferry, Judith ;
Geyer, Julia ;
Gratzinger, Dita ;
Guitart, Joan ;
Gujral, Sumeet ;
Harris, Marian ;
Harrison, Christine J. ;
Hartmann, Sylvia ;
Hochhaus, Andreas ;
Jansen, Patty M. ;
Karube, Kennosuke ;
Kempf, Werner ;
Khoury, Joseph ;
Kimura, Hiroshi ;
Klapper, Wolfram ;
Kovach, Alexandra E. ;
Kumar, Shaji ;
Lazar, Alexander J. ;
Lazzi, Stefano ;
Leoncini, Lorenzo ;
Leung, Nelson ;
Leventaki, Vasiliki ;
Li, Xiao-Qiu ;
Lim, Megan S. ;
Liu, Wei-Ping ;
Louissaint, Abner, Jr. ;
Marcogliese, Andrea .
LEUKEMIA, 2023, 37 (09) :1944-1951
[3]   High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma [J].
Aoki, T. ;
Shimada, K. ;
Suzuki, R. ;
Izutsu, K. ;
Tomita, A. ;
Maeda, Y. ;
Takizawa, J. ;
Mitani, K. ;
Igarashi, T. ;
Sakai, K. ;
Miyazaki, K. ;
Mihara, K. ;
Ohmachi, K. ;
Nakamura, N. ;
Takasaki, H. ;
Kiyoi, H. ;
Nakamura, S. ;
Kinoshita, T. ;
Ogura, M. .
BLOOD CANCER JOURNAL, 2015, 5 :e372-e372
[4]  
Avivi Irit, 2014, BLOOD, V124
[5]   The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome [J].
Bledsoe, Jacob R. ;
Redd, Robert A. ;
Hasserjian, Robert P. ;
Soumerai, Jacob D. ;
Nishino, Ha T. ;
Boyer, Daniel F. ;
Ferry, Judith A. ;
Zukerberg, Lawrence R. ;
Harris, Nancy Lee ;
Abramson, Jeremy S. ;
Sohani, Aliyah R. .
AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (10) :E436-E441
[6]   Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study [J].
Caimi, Paolo F. ;
Ai, Weiyun Z. ;
Alderuccio, Juan Pablo ;
Ardeshna, Kirit M. ;
Hamadani, Mehdi ;
Hess, Brian ;
Kahl, Brad S. ;
Radford, John ;
Solh, Melhem ;
Stathis, Anastasios ;
Zinzani, Pier Luigi ;
Wang, Ying ;
Qin, Yajuan ;
Wang, Luqiang ;
Xu, Zhiying Cindy ;
Stella, Carmelo Carlo- .
HAEMATOLOGICA, 2024, 109 (04) :1184-1193
[7]  
Camus V., 2022, Ann Lymphoma, V6, P13, DOI [10.21037/aol-22-13, DOI 10.21037/AOL-22-13]
[8]   Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study [J].
Camus, Vincent ;
Rossi, Cedric ;
Sesques, Pierre ;
Lequesne, Justine ;
Tonnelet, David ;
Haioun, Corinne ;
Durot, Eric ;
Willaume, Alexandre ;
Gauthier, Martin ;
Moles-Moreau, Marie-Pierre ;
Antier, Chloe ;
Lazarovici, Julien ;
Monjanel, Helene ;
Bernard, Sophie ;
Tardy, Magalie ;
Besson, Caroline ;
Lebras, Laure ;
Choquet, Sylvain ;
Le Du, Katell ;
Bonnet, Christophe ;
Bailly, Sarah ;
Damaj, Ghandi ;
Laribi, Kamel ;
Maisonneuve, Herve ;
Houot, Roch ;
Chauchet, Adrien ;
Jardin, Fabrice ;
Traverse-Glehen, Alexandra ;
Decazes, Pierre ;
Becker, Stephanie ;
Berriolo-Riedinger, Alina ;
Tilly, Herve .
BLOOD ADVANCES, 2021, 5 (19) :3862-3872
[9]   Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients [J].
Casadei, Beatrice ;
Argnani, Lisa ;
Morigi, Alice ;
Lolli, Ginevra ;
Broccoli, Alessandro ;
Pellegrini, Cinzia ;
Nanni, Laura ;
Stefoni, Vittorio ;
Coppola, Paolo Elia ;
Carella, Matteo ;
Cavo, Michele ;
Zinzani, Pier Luigi .
ANNALS OF HEMATOLOGY, 2021, 100 (09) :2261-2268
[10]   Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma [J].
Ceriani, Luca ;
Milan, Lisa ;
Martelli, Maurizio ;
Ferreri, Andres J. M. ;
Cascione, Luciano ;
Zinzani, Pier Luigi ;
Di Rocco, Alice ;
Conconi, Annarita ;
Stathis, Anastasios ;
Cavalli, Franco ;
Bellei, Monica ;
Cozens, Kelly ;
Porro, Elena ;
Giovanella, Luca ;
Johnson, Peter W. ;
Zucca, Emanuele .
BLOOD, 2018, 132 (02) :179-186